Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.23.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

72,529

$

44,499

$

138,724

$

86,427

General and administrative

 

347,228

 

375,454

 

689,239

 

637,331

Total stock-based compensation

$

419,757

$

419,953

$

827,963

$

723,758